GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyorin Pharmaceutical Co Ltd (TSE:4569) » Definitions » Forward Dividend Yield %

Kyorin Pharmaceutical Co (TSE:4569) Forward Dividend Yield % : 3.73% (As of May. 22, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kyorin Pharmaceutical Co Forward Dividend Yield %?

As of today (2024-05-22), the Forward Annual Dividend Yield of Kyorin Pharmaceutical Co is 3.73%.

As of today (2024-05-22), the Trailing Annual Dividend Yield of Kyorin Pharmaceutical Co is 3.03%.

TSE:4569's Forward Dividend Yield % is ranked better than
79.96% of 484 companies
in the Drug Manufacturers industry
Industry Median: 1.83 vs TSE:4569: 3.73

Kyorin Pharmaceutical Co's Dividends per Share for the three months ended in Dec. 2023 was 円0.00.

During the past 3 years, the average Dividends Per Share Growth Rate was -11.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -4.60% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 1.90% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Kyorin Pharmaceutical Co was 51.30% per year. The lowest was -11.50% per year. And the median was 5.10% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Kyorin Pharmaceutical Co's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Kyorin Pharmaceutical Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyorin Pharmaceutical Co's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyorin Pharmaceutical Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Kyorin Pharmaceutical Co's Forward Dividend Yield % falls into.



Kyorin Pharmaceutical Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Kyorin Pharmaceutical Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
JPY 32.0000002024-03-282024-03-312024-06-05Cash Dividendsemi-annuallyJPY:JPY 1.000000
JPY 20.0000002023-09-282023-09-302023-12-04Cash Dividendsemi-annuallyJPY:JPY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Kyorin Pharmaceutical Co's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=64/1714.00
=3.73 %

Current Share Price is 円1714.00.
Kyorin Pharmaceutical Co's Dividends per Share for the forward twelve months is calculated as 円32 * 2 = 円64.

Kyorin Pharmaceutical Co's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=52/1714.00
=3.03 %

Current Share Price is 円1714.00.
Kyorin Pharmaceutical Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is 円52.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kyorin Pharmaceutical Co  (TSE:4569) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Kyorin Pharmaceutical Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Kyorin Pharmaceutical Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyorin Pharmaceutical Co (TSE:4569) Business Description

Traded in Other Exchanges
N/A
Address
6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311
Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Kyorin Pharmaceutical Co (TSE:4569) Headlines

No Headlines